Plante Moran Financial Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,000
Closed -$37K 983
2022
Q1
$37K Hold
1,000
0.01% 375
2021
Q4
$45K Hold
1,000
0.01% 384
2021
Q3
$63K Hold
1,000
0.01% 337
2021
Q2
$92K Hold
1,000
0.02% 260
2021
Q1
$68K Hold
1,000
0.02% 302
2020
Q4
$72K Sell
1,000
-672
-40% -$38.9K 0.02% 287
2020
Q3
$63K Hold
1,672
0.02% 284
2020
Q2
$59K Hold
1,672
0.02% 273
2020
Q1
$36K Hold
1,672
0.02% 305
2019
Q4
$36K Buy
1,672
+672
+67% +$15.4K 0.01% 368
2019
Q3
$23K Hold
1,000
0.01% 465
2019
Q2
$36K Hold
1,000
0.01% 389
2019
Q1
$32K Sell
1,000
-500
-33% -$14.6K 0.01% 406
2018
Q4
$38K Hold
1,500
0.01% 341
2018
Q3
$43K Buy
+1,500
New +$28.1K 0.01% 334

Other funds holding CDNA

Plante Moran Financial Advisors's CDNA Position: Q2 2022 in Review

Plante Moran Financial Advisors sold out of CareDx (CDNA) in Q2 2022, closing a stake of 1,000 shares — an estimated $37K sold.

Plante Moran Financial Advisors first reported a position in CDNA in Q3 2018 and held it in 15 quarters. The position peaked at $92K in Q2 2021. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

  • Plante Moran Financial Advisors reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 1,000 CareDx shares in Q2 2022, an estimated $37K.
  • Plante Moran Financial Advisors first reported a position in CareDx in Q3 2018 and held it in 15 quarters.
  • Plante Moran Financial Advisors's CareDx position peaked at $92K in Q2 2021.
  • 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2022, filed 2 Aug 2022.